Five years ago, Viking Therapeutics (NASDAQ: VKTX) was an unknown, clinical-stage biotech. It hardly stood out in a sea of ...

The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...

New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.

However, GLP-1-based therapies aren't going to be the only option in the weight loss medicines market forever. Some companies ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...